stella
beta
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer — Stella
Recruiting
Back to Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov